Experiences with
Ceritinib36 public posts
Want to take advantage of all our features? Just log in!
or
Drug Submission time again. We are looking to speak to anyone who has experience of Loratinib (Lorviqua)
The indication this new medicine will be assessed under is: "As monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) whose disease has progressed after: Alectinib or ceritinib as the first ALK tyrosine